We thus validated these results by quantitative PCR and found a trend toward higher expression of ID4 and SOX2 in X‐ALD patients compared with controls, and a trend toward higher expression of ID4 in cALD than in cAMN (Figure 7C). The gene discussed is ID4; the disease is X-linked adrenoleukodystrophy.